Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.
Masatoshi NakagawaTakashi KarashimaMasayuki KamadaEisaku YoshidaToru YoshimuraMasanori NojimaKeiji InoueTaro ShuinMotoharu SeikiNaohiko KoshikawaPublished in: Biomarker research (2017)
These results suggest that urine monomeric laminin-γ2 may be a promising biomarker to diagnose cases of non-muscle invasive bladder cancer using a fully automated chemiluminescence immunoassay system.